Balding Men Haven’t Had a New Pill Since the 1990s. That’s About to Change
Veradermics' VDPHL01 is now all but guaranteed to win FDA approval for treating pattern baldness.
Via Gizmodo
An experimental hair loss treatment now looks set to become the first approved drug of its kind, following another successful large-scale clinical trial.
On Monday, the pharmaceutical company Veradermics reported the results of its double-blinded, randomized, and controlled Phase III trial for its treatment codenamed VDPHL01. Compared to placebo, significantly more people taking VDPHL01 experienced substantial hair growth, and with minimal side effects, the trial showed. Coupled with similar findings earlier this year, VDPHL01 is poised to easily secure approval…
Courtesy
This story was originally published by Gizmodo. All rights belong to the original publisher.
Read the original on gizmodo.com ↗